Both in Pharmaceuticals
Niagen Bioscience vs ALX Oncology Holdings
Over the past year NAGE returned −67.4% and ALXO returned −17.8%; their daily moves had a correlation of 0.17.
NAGE −67.4% ALXO −17.8%Growth of $1, one year, split-adjusted
| Metric | NAGE | ALXO |
|---|---|---|
| Price | $2.36 | $1.29 |
| Market cap | $186.7M | $178.4M |
| Today | −1.67% | −5.84% |
| 1 month | −11.9% | +6.6% |
| 6 months | −51.0% | −33.2% |
| Year to date | −62.9% | +14.2% |
| 1 year | −68.7% | −16.2% |
| Revenue growth (YoY) | −4.3% | — |
| Gross margin | 64.8% | — |
| Net margin | 3.2% | — |
| P/E (TTM) | 11.7× | — |
| Price / sales | 1.4× | — |
| Net cash | $66.7M | $128.5M |
| Dividend yield | — | — |
| Volatility (60d) | 37.2% | 93.1% |
| Short % of float | 8.0% | 6.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).